共 269 条
[1]
Wu WC(2016)EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease J Hepatol 64 1388-1402
[2]
Wu CY(2012)Updated thresholds for serum alanine aminotransferase level in a large-scale population study composed of 34 346 subjects Aliment Pharmacol Ther 36 560-568
[3]
Wang YJ(2013)Inverse association between hepatitis B virus infection and fatty liver disease: a large-scale study in populations seeking for check-up PLoS One 8 e72049-976
[4]
Hung HH(2013)Thirty-year outcomes of the national hepatitis B immunization program in Taiwan JAMA 310 974-511
[5]
Yang HI(2018)EASL recommendations on treatment of hepatitis C 2018 J Hepat 69 461-397
[6]
Kao WY(2015)Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease Gastroenterology 149 389-1565
[7]
Su CW(2017)Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis Hepatology 65 1557-2343
[8]
Wu JC(2015)Prevalence of non-alcoholic fatty liver disease and Steatohepatitis risk factors in patients undergoing bariatric surgery Obes Surg 25 2335-289
[9]
Chan WL(2016)Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery J Gastroenterol 51 281-56
[10]
Lin HC(2007)Diagnostic value of ultrasonographic examination for nonalcoholic steatohepatitis in morbidly obese patients undergoing laparoscopic bariatric surgery Obes Surg 17 45-894